Comparison Overview

Oncotarget

VS

Forbes India

Oncotarget

6666 East Quaker Street, 1A, Orchard Park, NY, US, 14127
Last Update: 2025-11-27
Between 750 and 799

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is indexed and archived by: PubMed MEDLINE PubMed Central Scopus EMBASE META (Chan Zuckerberg Initiative; 2018-2022) Dimensions (Digital Science) Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/ Learn about our FREE Post-Publication Promotion Services: https://www.oncotarget.com/editorial-policies/#post-publication-promotion

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: 9
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Forbes India

undefined, Mumbai, Maharashtra, 400013, IN
Last Update: 2025-11-26
Between 750 and 799

Forbes India, a Network18 venture in partnership with Forbes Media LLC, is India’s leading business magazine that helps readers understand the phenomenon behind news, connect the dots and get cutting-edge perspectives. Its senior editorial team has years of experience and produces a compelling package of short newsy features, in-depth articles and lifestyle stories every two weeks. Forbes India has been one of India's most sought-after and credible business magazines, since its launch on May 21, 2009. To subscribe to Forbes India, go to: http://forbesindia.com/subscription/

NAICS: 511
NAICS Definition:
Employees: 112
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/oncotarget.jpeg
Oncotarget
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/forbes-india.jpeg
Forbes India
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Oncotarget
100%
Compliance Rate
0/4 Standards Verified
Forbes India
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Oncotarget in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Forbes India in 2025.

Incident History — Oncotarget (X = Date, Y = Severity)

Oncotarget cyber incidents detection timeline including parent company and subsidiaries

Incident History — Forbes India (X = Date, Y = Severity)

Forbes India cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/oncotarget.jpeg
Oncotarget
Incidents

No Incident

https://images.rankiteo.com/companyimages/forbes-india.jpeg
Forbes India
Incidents

No Incident

FAQ

Forbes India company demonstrates a stronger AI Cybersecurity Score compared to Oncotarget company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Forbes India company has disclosed a higher number of cyber incidents compared to Oncotarget company.

In the current year, Forbes India company and Oncotarget company have not reported any cyber incidents.

Neither Forbes India company nor Oncotarget company has reported experiencing a ransomware attack publicly.

Neither Forbes India company nor Oncotarget company has reported experiencing a data breach publicly.

Neither Forbes India company nor Oncotarget company has reported experiencing targeted cyberattacks publicly.

Neither Oncotarget company nor Forbes India company has reported experiencing or disclosing vulnerabilities publicly.

Neither Oncotarget nor Forbes India holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Oncotarget company nor Forbes India company has publicly disclosed detailed information about the number of their subsidiaries.

Forbes India company employs more people globally than Oncotarget company, reflecting its scale as a Book and Periodical Publishing.

Neither Oncotarget nor Forbes India holds SOC 2 Type 1 certification.

Neither Oncotarget nor Forbes India holds SOC 2 Type 2 certification.

Neither Oncotarget nor Forbes India holds ISO 27001 certification.

Neither Oncotarget nor Forbes India holds PCI DSS certification.

Neither Oncotarget nor Forbes India holds HIPAA certification.

Neither Oncotarget nor Forbes India holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.